Computerized tomography and lymphangiography in staging testis tumors

Area of Science:

• Urology
• Oncology
• Diagnostic Imaging

Background:

• Accurate staging is crucial for nonseminomatous testicular tumors.
• Diagnostic imaging modalities like computerized tomography (CT) and lymphangiography are often used to assess retroperitoneal lymph node metastases.
• The role of tumor markers in conjunction with imaging requires further clarification.

Purpose of the Study:

• To evaluate the diagnostic utility of computerized tomography (CT), lymphangiography, and tumor markers in staging pathologic stage I or II nonseminomatous testicular tumors.
• To determine the accuracy of these methods in detecting retroperitoneal lymph node metastases.

Main Methods:

• Retrospective analysis of 20 consecutive patients with nonseminomatous testicular tumors.
• Assessment of computerized tomography (CT) and lymphangiography for staging accuracy.
• Correlation of imaging findings with tumor marker levels.

Main Results:

• Computerized tomography (CT) demonstrated a 69% overall accuracy with a 40% false negative rate and 50% false positive rate.
• Lymphangiography showed a 69% overall accuracy with a 42% false negative rate and 0% false positive rate.
• The combination of CT and lymphangiography did not significantly improve diagnostic accuracy. Tumor markers did not enhance the sensitivity of imaging for detecting metastases.

Conclusions:

• Neither computerized tomography (CT) nor lymphangiography alone or in combination reliably stages nonseminomatous testicular tumors.
• Tumor markers do not significantly improve the diagnostic accuracy of imaging for retroperitoneal lymph node metastases.
• Retroperitoneal lymphadenectomy remains the gold standard for accurate staging in patients with nonseminomatous testicular tumors.